Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12609000250235
ACTRN12609000250235
Completed
Phase 4

Calcium citrate and its effects on bone loss and hyperparathyroidism in renal transplant recipients

Dr Patrick T Coates0 sites35 target enrollmentMay 12, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBone loss in renal transplant recipients.Hyperparathyroidism in renal transplant recipients.Renal and Urogenital - Kidney diseaseMetabolic and Endocrine - Metabolic disordersMusculoskeletal - Osteoporosis

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Bone loss in renal transplant recipients.
Sponsor
Dr Patrick T Coates
Enrollment
35
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 12, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Patrick T Coates

Eligibility Criteria

Inclusion Criteria

  • •Previous renal transplant over 1 year ago.
  • •Stable renal function (Creatinine \< 150\) Standard immunosuppression regime (Tacrolimus, Mycophenolate Mofetil and Prednisolone).
  • •Able to give informed consent.
  • •Able to attend 3 sessions held over 1 week.

Exclusion Criteria

  • •Preexisting hypercalcemia (Ca \> 2\.55 mmol/L), severe hyperparathyroidism (PTH \> 50 pmol/L) or severe vitamin D insufficiency (serum 25\-hydoxy vitamin D \< 15 ng/mL).
  • •Previous parathyroidectomy.
  • •Concurrent use of bisphosphonates, Vitamin D analogues, lithium, phenytoin, carbamazepine, hormone replacement therapy, thiazide diuretics.
  • •Participation in a concurrent study.
  • •Pre\-menopausal women (due to low level radiation exposure).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Effects of calcium supplementation on bone mineral density in milk allergy childre
JPRN-UMIN000024182ational Hospital Organization Kumamoto Medical Center30
Recruiting
Not Applicable
Effects of etelcalcetide and cinacalcet on bone mineral density in patients with secondary hyperparathyroidismPatients on hemodialysis complicated with secondary hyperparathyroidism
JPRN-UMIN000027453Matsunami general hospital30
Completed
Not Applicable
Citrate Effects and Bone Density in Long-Term Apheresis DonorsHealthy Apheresis Donors
NCT00073060National Institutes of Health Clinical Center (CC)273
Completed
Not Applicable
Potassium Citrate to Prevent Age Related Bone LossOsteoporosis
NCT00282126University of California, San Francisco52
Recruiting
Not Applicable
Changes in bone mineral density and serum calcium levels after romosozumab treatmet in postmenopausal osteoporosis patients:About short-term results at 6 months
JPRN-jRCT1040190111Kobayakawa Tomonori60